Compare FormFactor Inc. FormFactor Inc. Common Stock (FORM) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FormFactor Inc. FormFactor Inc. Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? FormFactor Inc. FormFactor Inc. Common Stock trades at $139.44 (market cap $10.92B), while ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B). The key difference: FormFactor Inc. FormFactor Inc. Common Stock and ImmunityBio Inc. Common Stock are close in size by market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 1,056,924). Which is the better fit depends on your goals — on Pluang, investors hold FormFactor Inc. FormFactor Inc. Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| FORM | IBRX | |
|---|---|---|
Market Cap | $10.92B | $10.33B |
Volume | 1,056,924 | 11,745,198 |
Sector | Technology | Health |
52-Week High | $159.93 | $11.55 |
52-Week Low | $38.14 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.61B | $10.79B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FormFactor Inc. FormFactor Inc. Common Stock
FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
